94 related articles for article (PubMed ID: 9250794)
1. Somatostatin receptor scintigraphy in the staging of lymphomas.
Ivancević V; Wörmann B; Nauck C; Sandrock D; Munz DL; Hiddemann W; Emrich D
Leuk Lymphoma; 1997 Jun; 26(1-2):107-14. PubMed ID: 9250794
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP
J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
[TBL] [Abstract][Full Text] [Related]
3. The relevance of somatostatin receptor expression in malignant lymphomas.
van den Anker-Lugtenburg PJ; Löwenberg B; Lamberts SW; Krenning EP
Metabolism; 1996 Aug; 45(8 Suppl 1):96-7. PubMed ID: 8769395
[TBL] [Abstract][Full Text] [Related]
4. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
Sarda L; Duet M; Zini JM; Berolatti B; Benelhadj S; Tobelem G; Mundler O
Eur J Nucl Med; 1995 Oct; 22(10):1105-9. PubMed ID: 8542892
[TBL] [Abstract][Full Text] [Related]
5. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.
van den Anker-Lugtenburg PJ; Krenning EP; Oei HY; Van Hagen MP; Gerrits CJ; Reubi JC; Lamberts SW; Löwenberg B
Br J Haematol; 1996 Apr; 93(1):96-103. PubMed ID: 8611482
[TBL] [Abstract][Full Text] [Related]
7. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
Lipp RW; Schnedl WJ; Aglas F; Ranner G; Beham-Schmid C; Leb G; Sill H
Acta Med Austriaca; 1999; 26(3):105-8. PubMed ID: 10520379
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin analogue scintigraphy of malignant lymphomas.
Vanhagen PM; Krenning EP; Reubi JC; Mulder AH; Bakker WH; Oei HY; Löwenberg B; Lamberts SW
Br J Haematol; 1993 Jan; 83(1):75-9. PubMed ID: 8094627
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin-receptor imaging in lymphoma.
Goldsmith SJ; Macapinlac HA; O'Brien JP
Semin Nucl Med; 1995 Jul; 25(3):262-71. PubMed ID: 7570045
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor scintigraphy useful in stage I-II Hodgkin's disease: more extended disease identified.
Lugtenburg PJ; Krenning EP; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Löwenberg B
Br J Haematol; 2001 Mar; 112(4):936-44. PubMed ID: 11298588
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
12. [Ga-67 scintigraphy for the localization and staging of malignant lymphoma].
Monzawa S; Karikomi M; Uno K; Itami J; Arimizu N
Gan No Rinsho; 1988 Aug; 34(9):1059-64. PubMed ID: 3172511
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
Pelosi E; Penna D; Douroukas A; Bellò M; Amati A; Arena V; Passera R; Bisi G
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):469-75. PubMed ID: 21150862
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
15. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
[TBL] [Abstract][Full Text] [Related]
16. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
Hoh CK; Glaspy J; Rosen P; Dahlbom M; Lee SJ; Kunkel L; Hawkin RA; Maddahi J; Phelps ME
J Nucl Med; 1997 Mar; 38(3):343-8. PubMed ID: 9074514
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
Mouratidis B; Gilday DL; Ash JM
Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
Krause T; Eisenmann N; Reinhardt M; Bathmann J; Altehoefer C; Finke J; Moser E
Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]